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Introduction
Cancer of the oral tongue is traditionally treated by
different options like surgery and/or radiotherapy1-3, but
before any treatment is planned other factors like age, health
status, stage of the disease, functional and cosmetic out-
come, compliance with regular follow-up and acceptance of
the patient to the proposed treatment should be considered.
Tongue cancer carries a high risk for nodal metasta-
sis even in small or early stage lesions regardless of the fact
that the cervical lymph nodes are not palpable clinically,
which is reported to be true in about 30% of the cases4,5;
therefore the detection of occult neck disease in early stage
cancer remains a challenging problem. The presence or
absence of neck disease is an important factor not only for
staging and deciding the treatment modality but also for pre-
dicting prognosis in these patients.
The policy of treatment for occult neck disease is
still controversial and the option lies whether to observe
such patients or to treat them with surgery, irradiation or
both. The first treatment done for primary   tongue can-
cer or neck metastasis influences the final prognosis or
the survival of the patient. The decision to treat a clini-
cally negative neck is recommended by recent evidence,
which indicates that elective neck dissection offers a bet-
ter prognosis with reported reduction of regional recur-
rence and better survival for patients with occult nodal
disease.6
This study attempts to define the efficacy of differ-
ent locoregional treatment options for tongue cancer in
determining the prognosis, with reference to recurrence of
disease in neck.
Material and Methods
Medical charts of 157 patients who underwent treat-
ment for carcinoma of oral tongue during 14 years from
January 1989 to December 2003 at The Aga Khan
University Hospital were analyzed retrospectively.
Patients who had hemiglossectomy for histopatho-
logically established early stage (T1 / T2) squamous cell
carcinoma with primary surgical clear (>5mm) or close 5
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Abstract
Objective: To study the efficacy of different locoregional treatment options for tongue cancer in determining the
prognosis, with reference to recurrence of disease in neck.
Methods: This is a retrospective analysis of 80 patients with early (T1/T2) carcinoma tongue who had hemiglos-
sectomy with or without neck surgery and radiotherapy for 14 years.
Results: Eighty patients were included in this study, 49 (61.3%) men and 31 (38.8%) women; 36 (45%) patients
with T1 lesion and 44 (55%) with T2 lesion. Sixty two patients (77.5%) were staged cN0 and 18 patients had a
clinically palpable neck nodes (cN+). Thirty seven patients were pathologically negative (pN0), whereas 22 were
pathologically positive (pN+) and 21 were not operated so they were staged pathologically (pNx) (undissected
necks). Thirty patients received postoperative adjuvant radiotherapy. The median follow-up was 16.5 months with
a range of 10-120 months. The over-all rate of recurrence in neck was 32.5% (27 patients). The rate of recur-
rence was 23% in T1 and 45.8% in T2 lesion (P-value 0.09) without radiotherapy. The recurrence rates with T1
lesion patients who were given adjuvant radiotherapy did not change significantly whereas with T2 lesions the
recurrence rate decreased from 45% to 25% in the group without radiotherapy.
Recurrence rate was higher in undissected neck as compared to patients who underwent elective neck dissec-
tion having radiotherapy and staged pN0 (P-value 0.009) or pN+ (P-value 0.005). Patients having therapeutic
neck dissection, on comparison of final pathological node staging (i.e. pN0 or pN+) the rate of recurrence in
patients pN+ was 56% and in group with pN0 it was 11%, with (P-value 0.046).
Conclusion: We did not find any effect of age, gender and surgically resected margins of primary early tongue
tumor on recurrence of disease in neck. There was no significant difference between primary tumor stage T1 and
T2 lesions on neck recurrence when treated with surgery alone, but adjuvant radiotherapy further reduced the
neck recurrence in T2 groups. Adjuvant radiotherapy also showed a significant reduction in recurrence rates in
both pN0 and pN+. Undissected necks have higher incidence of neck recurrence than dissected neck irrespec-
tive of pathological status of neck metastasis (JPMA 56:448;2006).
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(1-5 mm) margins were included in this analysis.
Pre-operative staging was done by means of clinical exam-
ination or imaging studies; nodes less than 1 cm were staged
N0. The initial management was surgical intervention fol-
lowed by with or without radiotherapy. Patients who had a
minimum follow up of 10 months were included in this
study.
The results of treatment were analyzed for the devel-
opment of recurrence in neck. The pattern of failure was
determined by clinical and radiological examinations and
recurrence was defined when carcinoma developed in a dis-
sected neck or in an undissected neck.
The influence of surgery (primary and neck) and
radiotherapy on recurrence of disease in neck was evaluat-
ed by comparing the following groups  (1)  pNx         (2)
cN0 and pN0 (3) cN0 and pN + (4) cN+ and pN0 (5) cN+
and pN+; where cN indicates clinical neck status and pN
refers to pathological neck outcome and + and 0 stand for
positive and negative respectively. Those patients who did
not undergo neck dissection were termed as pNx.
In addition the effect of age, gender, surgical mar-
gins, T stage and adjuvant radiotherapy was also studied in
these patients.
Results
Out of 157 patients, 80 met the inclusion criteria and
were included in this study. There were 49 (61.3%) men and
31 (38.8%) women, with a mean age of 52.5 (range 15-87)
years. 
According to TNM Classification, there were 36
(45%) patients with T1 lesion and 44 (55%) with T2 lesion.
Sixty two patients (77.5%) were staged cN0 and of them 41
(66.1%) had elective neck surgery. Eighteen patients had
clinically palpable neck nodes (cN+) and all had neck sur-
gery. 
Out of the 41 patients (cN0) who underwent elective
neck dissection, 28 (68.29%) were staged pN0 and 13
(31.7%) were pN+.
Out of 18 patients (cN+) who had clinically palpable
neck nodes, all had neck dissection; only 9 were pathololog-
ically positive for metastasis (pN+). 
Therefore, histopathologically 37 patients were neg-
ative (pN0), whereas 22 were pathologically positive (pN+)
and 21 were not operated so they were  staged pathological-
ly (pNx) (undissected necks). 
All 80 patients had primary tongue tumor resection ,
61 out of 80 (76.3%) had a clear surgical margin i.e. the
margin was more than 5 mm from the tumor and 19 (23.8%)
had tumor excision close to the margin i.e. less than 5 mm
from the tumor shown in Table 1. Thirty patients received
postoperative adjuvant radiotherapy.  The median follow-up
was 16.5 months with a range of 10-120 months.
The overall rate of recurrence in neck was 32.5% (27
patients). Out of these 27 patients 7 were pN0 group, 9 were
pN+ and 11 were pNx. The average time for recurrence
was16 (range 3-48) months in the undissected necks and
21(range 4-77) months in the dissected necks and
Variable   No. of patients %
Sex 
Male
Female
Age (years)
< 40
> 40
Clinical Neck Stage
cN0
cN+
Final Neck Stage
pN0
pN+
pNx
Final T Stage
T1
T2
Final T and N Stage 
T1N0
T1N+
T1Nx
T2N0
T2N+
T2Nx
Surgical Margins
Clear
Close to Excision
Adjuvant Radiotherapy
Received
Not Received
49
31
18
62
62
18
37
22
21
53
27
15
22
16
05
17
5
61
19
30
50
61.3
38.8
22.5
77.5
77.5
22.5
46.2
27.5
26.2
66.2
33.7
18.7
27.5
20.0
06.2
21.2
6.2
76.3
23.8
37.5
62.5
Table 1. Clinical characteristics of 80 patients with early stage
Carcinoma of oral tongue.
Variable % of patients with recurrence P-value
Age
< 40
> 40
Sex
Male
Female
Surgical Margins
Clear Margins
Close to excision
T-Stage
T1
T2
Radiotherapy
Without radiotherapy
With radiotherapy
33.3%
32.3%
30.6%
35.5%
32.8%
31.6%
27.8%
36.4%
34.0%
30.0%
0.93
0.65
0.92
0.41
0.71
Table 2. Factors and rate of recurrence (Univariate Analysis).
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21(range 4-77) months in the dissected necks.
Table 2 shows factors associated with recurrence.
The overall rate of recurrence was similar when patients less
than 40 years of age were compared with those who were
more than 40 (p < 0.932). No significant association was
found on comparing gender for rate of recurrence (p < 0.65).
The patients with close and clear surgical margins
were compared, but no statistical difference was found (P-
value 0.92) in these two groups. The rate of neck recurrence
in the group with T1 lesion was 27.8%, whereas it was high-
er in patients with T2 lesion (36.4%) however, there was no
statistically significant difference (p < 0.41) between them.
Overall the rate of recurrence was higher in patients with
undissected neck (38%) when compared to dissected necks
having positive (36%) and negative (27%) node status.
Overall 30% patients with radiotherapy developed recur-
rence as against 34% those without radiotherapy         (p<
0.71).
Table 3 shows the multivariate analysis of the factors
associated with recurrence. 
On comparing patients with primary T1 and T2
lesions who did not receive radiotherapy, it was found that
the rate of recurrence was 23.1% in T-1 lesion and 45.8% in
T-2 lesions (p < 0.09). With the addition of adjuvant radio-
therapy there was no significant change in neck recurrence
in patients with T1 lesions but these rates fell from 45% to
25% in patients with T2 lesions.
Within the group cN0, on comparison of pN0, pN+
and pNx, it was seen that the group, with pNx had a higher
rate of recurrence compared to those subjected to dissection
and had a pathologically uninvolved neck (pN0). There was
a statistically significant difference (p <  0.009) when both
of these groups were compared with respect to radiotherapy.
The patients with pNx were also compared to those
who had cN0 and had elective neck dissection and were
pathologically positive (pN+), it was seen that the recur-
rence rates were significantly higher in undissected necks.
(p < 0.005).
Within the group having therapeutic neck dissection
(cN+), when the patients with histopathologically positive
nodes (pN+), were compared to those having negative
nodes (pN0) , it was seen that pN+ group had a higher rate
of recurrence (56%) versus pN0 (11%) (p < 0.046). When
patients with pN0 were compared with those with undis-
sected necks, it was observed that the rate of recurrence in
undissected neck (88.9%) was again higher than those with
pN0 (11.1%).
In those patients who had neck surgery and adjuvant
radiotherapy, in group pN0 the rate of recurrence decreased
from 41.2% to 18.2% (p < 0.203), whereas in the group
pN+, the rate of recurrence decreased from 50.0% to 11.1%
(p < 0.125).
Discussion
In early carcinoma of tongue with clinically palpable
neck nodes, surgery is usually the first choice of treatment.
But for clinically non palpable neck nodes there are two
options. One is elective neck dissection and the other is
observation. Elective neck dissection itself entails low mor-
bidity and allows accurate node staging, but it may be an
unnecessary operation in some patients, and adjuvant radia-
tion may be required when dissected nodes turn out to be
metastatic lymphadenopathy. To manage the patients with
carcinoma of tongue, locoregional control is crucial for sur-
vival, as majority die of locoregional recurrence other than
distant disease.  The optimal treatment of these patients is
locoregional control, without jeopardizing the functions and
cosmesis of head and neck. To decide which treatment
method is to be adopted there is a need to identify the reli-
able prognostic factors for locoregional disease control and
survival.
In our study mean age of our patients at diagnosis
was 52.5 years (range 15-87 years), which was similar to
that reported in literature.7 The proportion of women
(38.8%) was less then men (61.3%), which is different than
that reported in western studies8, because Ca tongue is on
the rise in female population due to popularity of smoking,
while smoking is not very commonly encountered in
women in our society.
On univariate analysis, neck recurrence of disease
in our study population was 33.3% in patients less then 40
years of age and 32.3% in age group more then 40 years. In
literature some authors  reported higher recurrence rate in
the younger patients.11-13 Other studies concluded that there
is no significant difference between the age groups9,10,14,15
Table 3. Factors for recurrence (Multivariate Analysis).
Variable P-value
T Stage without radiotherapy
T1 Stage
T2 Stage
Clinically Negative Neck (cN0) without radiotherapy
pN+
pNx
pN0
pNx
Clinically Negative Neck (cN0) with radiotherapy
pN0
pNx
pN+
pNx
Clinically postive Neck (cN+) 
pN0
pN+
0.09
0.56
0.48
0.009
0.005
0.046
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which is similar to our study. 
The primary surgical margins are important prognos-
tic factors in relation to recurrence at primary site, El-
Husseiny et al16,  Amdur et al17 and Kirita et al18 reported
higher recurrence rate with involved margins and decreased
recurrence at local site with clear margins.  
The rate of recurrence of disease in neck in the group
of patients with T1 lesion was 27.8% and slightly higher in
patients with T2 lesion 36.4%. Similar results were report-
ed by El-Hussain et al16, and Mitchell and Gighton.19
On univariate analysis of patients who had neck dis-
section only, the rate of recurrence for patients with patho-
logically negative (pN0) neck was 41.2% and in group of
patients with pathological positive neck (pN+) was 50%.
But when these patients were compared with group of
patients who were given adjuvant radiotherapy, the rate of
recurrence in neck for pN0 dropped from 41.2% to 18.2%
and in group pN+ from 50% to 11.1%.  These results are
similar to those reported by Shingoki et al20 and El-
Hussaini.16
On multivariate analysis of factors of recurrence it
was seen that patients who were not treated surgically i.e.
pNx had a higher rate of recurrence than the patients who
had neck dissection with final p stage of pN0.  Statistically
it was more significant when undissected neck was com-
pared to patients with pN0 and adjuvant radiotherapy.
Anthony et al21 reported similar results, with low recurrence
in patients who had elective neck dissection and were given
adjuvant radiotherapy. 
When patients with undissected neck (pNx) were
compared to patients who had elective neck dissection cN0
and were pN+, the rate of recurrence was significantly high-
er in undissected necks. In literature other studies also sup-
port our results.22,23
In conclusion, we did not find any effect of age, gen-
der and surgical resection margins of primary early tongue
tumour on recurrence in the neck. There was no significant
difference between primary tumour stage T1 and T2 lesions
on neck recurrence when treated with surgery alone, but
adjuvant radiotherapy further reduced the neck recurrence
in T2 groups while there was no significant difference in T1.
Adjuvant radiotherapy also showed a significant reduction
in recurrence rates in both pN0 and pN+. Undissected necks
have higher frequency of neck recurrence than dissected
neck irrespective of pathological status of neck metastasis. 
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